02:27 PM EDT, 05/07/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.)

Elanco Animal Health ( ELAN ) shares were up nearly 21% in recent Wednesday trading after the company reported higher Q1 adjusted earnings and revenue that topped analysts' estimates and raised its full-year revenue guidance.

The company reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.

Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.

Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.

For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.

Price: 11.50, Change: +1.99, Percent Change: +20.87